ADVERTISING

Bausch+Lomb

Interruption

Agency: Point Blank

Description

Globally, Glaucoma is the second leading cause of blindness after cataract. In India, approximately 11 million people have lost their vision due to this incurable disease. Compliance is a major concern in treating Glaucoma as nearly 50% of patients admit non-continuous use of medications by 6 months after start of therapy. Multiple dosing limits patient’s adherence to the treatment and thereby, worsens the condition. Patients feel that the treatment of Glaucoma is inconvenient and interferes with their day-to-day life. Bausch+Lomb’s Travoflo is a convenient once-daily-dosing therapy for Glaucoma, which is aimed at improving patient compliance by reducing the number of interruptions and improving the overall outcome.

This professional campaign titled 'Interruption' was published in India in November, 2013. It was created for the brand: Bausch+Lomb, by ad agency: Point Blank. This Print medium campaign is related to the Health industry and contains 3 media assets. It was submitted over 10 years ago.

Credits

Advertising Agency: POINTBLANK Advertising, Mumbai, India

Director: Bindu Menon

Creative Head: Sujeesh Sukumaran 

Art Directors: Pankaj Bhatia, Krishna Kumkar

Copywriters: Smruthy Nair, Guruguhan Iyer

Account Manager: Ruchelle Dias

Account Executive: Shreyas Pinglekar


ReeLabs
The Cortoz

ADVERTISING

Sign up for our newsletter

Don't miss out. Receive our free weekly newsletter to learn about the best creative work from all around the globe. We're keeping your email safe and confidential.